We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Edwards Lifesciences Corp | NYSE:EW | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.75 | -0.87% | 85.09 | 86.32 | 84.82 | 85.73 | 1,724,502 | 21:28:53 |
From May 2019 to May 2024
By Allison Prang
Edwards Lifesciences Corp., a medical devices company, logged higher earnings and net sales in its fourth quarter.
Edwards' earnings grew to $309.5 million, or 49 cents a share. Net income the comparable quarter a year prior was $280.2 million, or 44 cents a share.
Adjusted earnings were 50 cents a share. According to FactSet, analysts were expecting 53 cents a share.
Net sales rose 1.5% to $1.19 billion. Analysts were expecting $1.18 billion.
Shares of the company declined 3.35% to $82 in after-hours trading.
Write to Allison Prang at allison.prang@wsj.com
(END) Dow Jones Newswires
January 27, 2021 16:43 ET (21:43 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Edwards Lifesciences Chart |
1 Month Edwards Lifesciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
